Development of trastuzumab conjugated dendrimer nanoconjugates for targeted delivery of docetaxel
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: KULHARI, Hitesh (CSIR-Indian Institute of Chemical Technology,, IICT-RMIT Research Centre,, Hyderabad, India)
- Co-author(s): Kulhari (CSIR-Indian Institute of Chemical Technology,, Hyderabad, India)
Adams, D.J. (RMIT University, Melbourne, Austria)
Sistla (CSIR-Indian Institute of Chemical Technology,, Hyderabad, India)
Backgrounds: Current cancer chemotherapy suffers from the major disadvantage of lack of specificity and hence leading to severe toxicity to normal cells. Nanocarriers offer many advantages over free drug through passive and active targeting (1). The unique structure makes dendrimer an excellent building block to create an ideal polymeric.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.